Following Germany pharmaceutical firm Bayer’s acquisition of major Merck assets, reports say Bayer will keep several popular brands to the disappointment of several suitors that were looking to snatch up the businesses.
Reports say Bayer will maintain the Dr. Scholl’s and Coppertone brands following the $14 billion buyout of US-based Merck assets. Unnamed sources told reporters that several rivals had looked to acquire the brands, which did not seem to fit in with Bayer’s strictly pharmaceutical portfolio.
But Bayer plans to keep the companies, leading the company to broaden its healthcare businesses into consumer goods.
According to reports, Dr. School’s and Coppertone are each worth about $1 billion. They were part of the acquisition finalized last May following a bidding war with Reckitt Benckiser, Procter & Gamble and Novartis, according to reports.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google ExecAdmitted Firm’s Goal Was to “Crush” Digital Ad Rivals, According to Court Docs
Sep 11, 2024 by
CPI
Former Michigan Football Stars File $50 Million Antitrust Lawsuit Against NCAA
Sep 11, 2024 by
CPI
Oasis Fans Could Be in Line for Ticket Refunds Amid Antitrust Concerns
Sep 11, 2024 by
CPI
FCC Chair Calls for More Competition to SpaceX’s Starlink Network
Sep 11, 2024 by
CPI
Singapore Salon Director Jailed for Contempt in Consumer Protection Case
Sep 11, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI